85 related articles for article (PubMed ID: 32562952)
1. ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells.
Dhyani A; Favaro P; Olalla Saad ST
Blood Cells Mol Dis; 2020 Sep; 84():102460. PubMed ID: 32562952
[TBL] [Abstract][Full Text] [Related]
2. ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth.
Dhyani A; Machado-Neto JA; Favaro P; Saad ST
Eur J Cancer; 2015 Jan; 51(2):252-9. PubMed ID: 25483783
[TBL] [Abstract][Full Text] [Related]
3. ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells.
Dhyani A; Duarte AS; Machado-Neto JA; Favaro P; Ortega MM; Olalla Saad ST
FEBS Lett; 2012 Dec; 586(24):4311-8. PubMed ID: 23142581
[TBL] [Abstract][Full Text] [Related]
4. The feedback loop of ANKHD1/lncRNA MALAT1/YAP1 strengthens the radioresistance of CRC by activating YAP1/AKT signaling.
Yao PA; Wu Y; Zhao K; Li Y; Cao J; Xing C
Cell Death Dis; 2022 Feb; 13(2):103. PubMed ID: 35110552
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the Molecular Properties and Function of ANKHD1, and Its Role in Cancer.
Mullenger JL; Zeidler MP; Fragiadaki M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629022
[TBL] [Abstract][Full Text] [Related]
6. ANKHD1 contributes to the malignant phenotype of triple-negative breast cancer cells.
de Almeida BO; de Almeida LC; Costa-Lotufo LV; Machado-Neto JA
Cell Biol Int; 2022 Sep; 46(9):1433-1446. PubMed ID: 35842770
[TBL] [Abstract][Full Text] [Related]
7. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells.
Machado-Neto JA; Lazarini M; Favaro P; de Melo Campos P; Scopim-Ribeiro R; Franchi Junior GC; Nowill AE; Lima PR; Costa FF; Benichou S; Olalla Saad ST; Traina F
Biochim Biophys Acta; 2015 Mar; 1853(3):583-93. PubMed ID: 25523139
[TBL] [Abstract][Full Text] [Related]
8. Histone H2AX phosphorylation after cell irradiation with UV-B: relationship to cell cycle phase and induction of apoptosis.
Halicka HD; Huang X; Traganos F; King MA; Dai W; Darzynkiewicz Z
Cell Cycle; 2005 Feb; 4(2):339-45. PubMed ID: 15655354
[TBL] [Abstract][Full Text] [Related]
9. ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
Zhou Z; Jiang H; Tu K; Yu W; Zhang J; Hu Z; Zhang H; Hao D; Huang P; Wang J; Wang A; Xiao Z; He C
J Exp Clin Cancer Res; 2019 Jan; 38(1):18. PubMed ID: 30646949
[TBL] [Abstract][Full Text] [Related]
10. Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processes.
Almeida BO; Machado-Neto JA
BMB Rep; 2020 Aug; 53(8):413-418. PubMed ID: 32635985
[TBL] [Abstract][Full Text] [Related]
11. ANKHD1 silencing suppresses the proliferation, migration and invasion of CRC cells by inhibiting YAP1-induced activation of EMT.
Yao P; Li Y; Shen W; Xu X; Zhu W; Yang X; Cao J; Xing C
Am J Cancer Res; 2018; 8(11):2311-2324. PubMed ID: 30555746
[TBL] [Abstract][Full Text] [Related]
12. Molecular and functional characterization of a novel splice variant of ANKHD1 that lacks the KH domain and its role in cell survival and apoptosis.
Miles MC; Janket ML; Wheeler ED; Chattopadhyay A; Majumder B; Dericco J; Schafer EA; Ayyavoo V
FEBS J; 2005 Aug; 272(16):4091-102. PubMed ID: 16098192
[TBL] [Abstract][Full Text] [Related]
13. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
[TBL] [Abstract][Full Text] [Related]
14. ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells.
Traina F; Favaro PM; Medina Sde S; Duarte Ada S; Winnischofer SM; Costa FF; Saad ST
Biochim Biophys Acta; 2006 Sep; 1762(9):828-34. PubMed ID: 16956752
[TBL] [Abstract][Full Text] [Related]
15. The histone methyltransferase DOT1L is required for proper DNA damage response, DNA repair, and modulates chemotherapy responsiveness.
Kari V; Raul SK; Henck JM; Kitz J; Kramer F; Kosinsky RL; Übelmesser N; Mansour WY; Eggert J; Spitzner M; Najafova Z; Bastians H; Grade M; Gaedcke J; Wegwitz F; Johnsen SA
Clin Epigenetics; 2019 Jan; 11(1):4. PubMed ID: 30616689
[TBL] [Abstract][Full Text] [Related]
16. DNA-protein cross-links and replication-dependent histone H2AX phosphorylation induced by aminoflavone (NSC 686288), a novel anticancer agent active against human breast cancer cells.
Meng LH; Kohlhagen G; Liao ZY; Antony S; Sausville E; Pommier Y
Cancer Res; 2005 Jun; 65(12):5337-43. PubMed ID: 15958581
[TBL] [Abstract][Full Text] [Related]
17. Histone H3K79 demethylation by KDM2B facilitates proper DNA replication through PCNA dissociation from chromatin.
Kang JY; Park JW; Hahm JY; Jung H; Seo SB
Cell Prolif; 2020 Nov; 53(11):e12920. PubMed ID: 33029857
[TBL] [Abstract][Full Text] [Related]
18. Gap-filling and bypass at the replication fork are both active mechanisms for tolerance of low-dose ultraviolet-induced DNA damage in the human genome.
Quinet A; Vessoni AT; Rocha CR; Gottifredi V; Biard D; Sarasin A; Menck CF; Stary A
DNA Repair (Amst); 2014 Feb; 14():27-38. PubMed ID: 24380689
[TBL] [Abstract][Full Text] [Related]
19. Perturbed gap-filling synthesis in nucleotide excision repair causes histone H2AX phosphorylation in human quiescent cells.
Matsumoto M; Yaginuma K; Igarashi A; Imura M; Hasegawa M; Iwabuchi K; Date T; Mori T; Ishizaki K; Yamashita K; Inobe M; Matsunaga T
J Cell Sci; 2007 Mar; 120(Pt 6):1104-12. PubMed ID: 17327276
[TBL] [Abstract][Full Text] [Related]
20. Chromatin assembly during S phase: contributions from histone deposition, DNA replication and the cell division cycle.
Krude T; Keller C
Cell Mol Life Sci; 2001 May; 58(5-6):665-72. PubMed ID: 11437228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
